# LINACLOTIDE
> **ANDA209564** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2021-02-09
## Drug
- **FDA Application Number:** ANDA209564
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LINACLOTIDE
- **Generic name:** Linaclotide
- **Active ingredients:** LINACLOTIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** MYLAN
- **First approval:** 2021-02-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209564)
---
*MORVS · CC0 1.0*